NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Abingworth’

19 May 2014

US biopharma Proteon Therapeutics raises $45m Series D

US biopharmaceutical company Proteon Therapeutics has closed a $45m of Series D equity financing, including a $25m tranche to fully fund the first Phase 3 clinical study of its lead product.

28 February 2014

Abingworth raises £225m for tenth life sciences fund

Life sciences and healthcare investor Abingworth has held the final closing of its tenth fund, exceeding its £200m target and raising £225m.

10 October 2013

Abingworth raises more than £200m for latest fund

life science test tube_sq UK-based venture capital firm Abingworth has raised more than $200m for its sixth fund, AltAssets has learned.

8 October 2013

Personalis raises $22m in Abingworth-led Series B

Menlo Park-based startup Personalis, which provides medical exome and genome sequencing and interpretation services, has received $22m in Series B capital.

15 May 2013

Apple Tree and Novartis back Tokai’s $35m Series E

pharmaceutical 12_sq Cancer-focused biotech firm Tokai Pharmaceuticals has wrapped up a $35m Series E round, which was supported by existing investors Apple Tree Partners and Novartis Venture Funds.

8 April 2013

GenSight Biologics raises €32.2m from four venture capital firms

Paris-based gene therapy specialist GenSight Biologics has raised €32.2m via a Series A round, which was co-led by Novartis Venture Fund, Abingworth, Versant Ventures and Index Ventures.

6 March 2013

Abingworth, Third Point back $43m Avedro Series D

Venture capital firm Abingworth has led a $43m Series D financing round for eye condition treatment company Avedro.

20 February 2013

Women’s healthcare company Gynesonics raises $21m from VC investors

A group of venture capital firms has stumped up $21m in a Series D financing round for US-based women’s healthcare company Gynesonics.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014